© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Generic Liraglutide Approved, Marking First Generic GLP-1 RA Indicated Specifically for Weight Management in the US
August 29, 2025
Teva announced approval of the generic formulation of Saxenda, which could help expand access to the extremely popular class of antiobesity medications.
FDA Approves First New Treatment for Fibromyalgia in Over 15 Years: Daily Dose
August 29, 2025
Your daily dose of the clinical news you may have missed.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
August 28, 2025
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
One in Ten Individuals Initiate GLP-1 Therapy Within 5 Years of Bariatric Surgery, Study Finds
August 28, 2025
In a trial of over 112 000 US adults, researchers found that 14% started a GLP-1 receptor agonist after bariatric surgery.
American College of Cardiology: How to Address Barriers to Immunization for Adults With CVD
August 28, 2025
The ACC provides evidence-based guidance on improving vaccine uptake in vulnerable patients, addressing vaccine hesitancy, and improving overall vaccine access.
Shingles Vaccine Linked to Reduced Cardiovascular Risk in Global Meta-Analysis: ESC Preview
August 28, 2025
ESC 2025: The first global investigation of evidence for the potential positive connection is encouraging, but more research is needed to understand causality.
JN.1 COVID-19 Booster Safety Confirmed in Large Study: Daily Dose
August 28, 2025
Your daily dose of the clinical news you may have missed.
Fall 2025 Vaccine Update: Expert Insights on Coadministration, Policy Shifts, and Hesitancy
August 27, 2025
Infectious disease and family medicine experts share guidance on vaccine policy changes, patient communication, and boosting vaccine confidence.
A Family Physician Explains Why Primary Care Can't Afford to Miss Signs of Suicide Risk
August 27, 2025
Teresa Lovins, MD, sees at least 1 or 2 patients a week who have suicidal ideation. Too many of them are at risk for an attempt within a month of those visits.
Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults With Atopic Dermatitis
August 27, 2025
MRGPRX2 antagonism is the only known mechanism of action designed to modulate mast cells and sensory neurons, both key drivers of lesions and itch in AD.